NCT04633850View on ClinicalTrials.gov

Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

April 28, 2021

Study Completion Date

April 28, 2021

Conditions
Postoperative PainLung CancerVideo Assisted Thoracoscopic SurgeryThoracoscopic SurgeryNerve BlockLocal Anesthesia
Interventions
DRUG

Dexamethasone

Intravenous dexamethasone 8 mg. Given once at the end of surgery.

DRUG

Bupivacain

"Bupivacaine dose according to weight. \<60 kg: Total dose 100mg 60-90kg: Total dose 150mg \>90kg: Total dose 200mg~Given once at the end of surgery."

Trial Locations (1)

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Jannie Bisgaard Stæhr

OTHER

NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients | Biotech Hunter | Biotech Hunter